Navigation Links
Bristol-Myers Squibb, New Jersey Children's Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
Date:11/30/2007

NEW BRUNSWICK, N.J., Nov. 30 /PRNewswire-FirstCall/ -- Underscoring its worldwide commitment to children with HIV/AIDS, Bristol-Myers Squibb Company (NYSE: BMY) today joined Robert Wood Johnson University Hospital in opening a new clinical center at The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital. The new center is dedicated to research and treatment of children's immune system disorders and infectious diseases.

The Bristol-Myers Squibb Pediatric Infectious Disease and Immunology Center is one of three new clinical centers at the children's hospital made possible by a $5 million gift from the Bristol-Myers Squibb Foundation.

"At Bristol-Myers Squibb, we believe that together we can prevail over serious illness," said Jill DeSimone, senior vice president of the company's U.S. Virology division. "We are committed as a company in the battle against HIV/AIDS here in our community and throughout the world, and we stand united with others who are working to improve the lives of children and all people afflicted with this debilitating disease."

The new infectious disease and immunology center is the latest example of the company's support for the New Brunswick children's hospital, built in part with a philanthropic gift from Bristol-Myers Squibb Foundation. The center will not only treat pediatric HIV, it will also focus on emerging resistant infections, including those caused by community-acquired methicillin resistant Staphylococcus aureus (MRSA).

This past spring, The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital opened a pediatric rheumatology center dedicated to the research and treatment of rheumatic diseases such a
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
11. Allegheny General Hospital Performs First Liver Transplant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...Newswire/ -- Althea Technologies, Inc., a leading ... for biopharmaceutical products announced the addi...company,s platform of services, which will be over...rector of Formulation Development. This investment...cal scientists, along with new laboratory faciliti...
(Date:11/5/2009)...5 Helix BioPharma Corp. ...hat its Phase II trial of Topical Interferon Alpha...as completed patient enrollment, with the required..., The double-blind and placebo-controlled Phase II...and Sweden. Patients participating in the trial s...
(Date:11/5/2009).... 5 Renee Cobos, MD, a board certi...atology at the University of California, Irvine, a...tremendous results with Thermage CPT®. The up...g and contouring, features a new vibrating hand pi... patient comfort. ,, "Thermage has always been...
Breaking Medicine Technology:Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Travel Precautions Critical During Swine Flu Season 57731 1Travel Precautions Critical During Swine Flu Season 57731 2Travel Precautions Critical During Swine Flu Season 57731 3Wraps Coming Off Nearly Nude Senior Calendar in Unique Ceremony 57729 1Wraps Coming Off Nearly Nude Senior Calendar in Unique Ceremony 57729 2Wraps Coming Off Nearly Nude Senior Calendar in Unique Ceremony 57729 3Wraps Coming Off Nearly Nude Senior Calendar in Unique Ceremony 57729 4Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 1Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 2Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 3Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 4Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 5Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 6Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 7Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 8Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5021 9
...maceuticals,Inc., a privately-held biopharmaceutic...l trial of its first compound, A-002, for the trea... suggest that treatment with A-002,resulted in sig...sterol,Non- High Density Lipoprotein Cholesterol (...l (LDL-C), known as "bad" cholesterol, coupled wit...
...N and,the Discovery Channel aired the documentary,...environmental and resource issues around the,globe...forts like this that,look holistically at our plan.... As part of the documentary, biomonitoring, the m...sues and body fluids was highlighted as,Anderson C...
Other Medicine Technology:Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial 2Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial 3ACC Concerned Over Reporting of Biomonitoring Results 2ACC Concerned Over Reporting of Biomonitoring Results 3
(Date:11/8/2009)..., Nov. 8 Today, the nat...ives on passing, the Affordable Health Care for Am... important step in reforming America,s healthcare ...ors Annual Meeting in Providence (RI), mayors from...h care reform principles of reducing the long-term...
(Date:11/8/2009)...ses House Passage of Health Care Reform Bill ,... improve coverage for all Americans ,, HARRISB..., SUMMARY: Last night the United States House o...rm legislation that would strengthen Medicare for ...ies that prices millions of Americans out of affor...
(Date:11/8/2009)...ts and Crushing Taxes Nail Nation,s Job Creators ,... In response to U.S. House passage of the health c...eneurship Council (SBE Council) president & CE...,, "Make no mistake, those voting for H.R. 3962...gher costs and crushing taxes and penalties. Even ...
(Date:11/8/2009)... 3D Global Solutions is pleased to announ... the proposal effort for ReSound who recently rece...ng Aid contract. The award includes not only the V... Defense and other federal agencies. , ...9 -- 3D Global Solutions is pleased to announce th...
(Date:11/8/2009)..., Nov. 7 Today, the Hou...ptur, Dahlkemper, Smith, Ellsworth and Lipinski am... Act" (H.R. 3962). The amendment maintains the cur...tion and for benefits packages that include aborti...receive affordability credits and those who do not...
Breaking Medicine News(10 mins):Health News:The Nation's Mayors Commend House Passage of Health Reform Bill 2Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2
...sk for heart disease, 56% risk of ischemic stroke,...ay News) -- Women exposed to secondhand smoke at h... risk of peripheral artery disease (PAD) compared ...e in women," lead author Yao He, a professor of ep...
...ets stressed, even babies. , Now, it appears how...ve a particular form of a certain gene, according ...na at Chapel Hill. , Just as significantly, rese...es who initially do not respond well to stressful ...
...e for CalPERS Open Enrollment -, SAN FRANCISCO, S...lifornia have signed a multi-year agreement under,... Blue Shield members at,NorthBay,s two community h...nd PPO members will have access,to NorthBay,s phys...
...core the title of Body By Milk MVP, PECK, Mich., ...ond nature to the superstar athletes at Peck High ...campaign announced today that the,Pirates Varsity ... Refuel Your School contest which rewards high sch...
...ts who receive stereotactic radiosurgery (SRS) and...tment of metastatic brain tumors have more than tw...blems than those treated with SRS alone, according...s 50th annual meeting of the American Society for ...
...sed on the brink of phenomenal,growth, the adminis...n,aggressive, innovative branding firm that could ... campaign for all future PHC marketing efforts., ... of Record as of July 2008., Blue Clover,s respon...
Other Medicine News:Health News:Women's Peripheral Artery Disease Tied to Secondhand Smoke 2Health News:UNC study: Parenting can override effect of genes in how babies respond to stress 2Health News:Blue Shield of California and NorthBay Healthcare Reach an Agreement 2Health News:Peck School Wins National got milk?(R) Refuel Your School Contest 2Health News:Peck School Wins National got milk?(R) Refuel Your School Contest 3Health News:Whole brain radiation increases risk of learning and memory problems in cancer patients 2Health News:Whole brain radiation increases risk of learning and memory problems in cancer patients 3Health News:Physicians Health Choice Hires Blue Clover as Agency of Record 2
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: